pediatric patients

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

August 19, 2026

Teva Pharmaceutical Industries Ltd Ecopipam (EBS-101) is a first-in-class selective D1 (dopamine) receptor antagonist with Orphan Drug designation NDA…

MMedication

FDA Greenlights Glenmark's Ryaltris Allergy Spray for Children Ages 6-12, ETPharma

July 22, 2026

Mumbai: Glenmark Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved the expanded use of…

MMedication

SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease

June 27, 2026

SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or…

HHealthcare

U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

June 11, 2026

Approval expands HYMPAVZI use to now include people with hemophilia A or B ages 12 years and older…

MMedication

Novo Nordisk Expands GLP-1 Reach With Oral Ozempic And Pediatric Push

May 2, 2026

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…

HHealth

January 15, 2026

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online…

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

FDA Greenlights Glenmark’s Ryaltris Allergy Spray for Children Ages 6-12, ETPharma

SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease

U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Novo Nordisk Expands GLP-1 Reach With Oral Ozempic And Pediatric Push

Early Release – Case Series of Bacteremia Associated with Probiotic Use in Children after Cardiac Surgery, China – Volume 32, Number 1—January 2026 – Emerging Infectious Diseases journal